| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.42B | 37.50B | 36.51B | 32.37B | 30.90B | 31.81B |
| Gross Profit | 11.75B | 11.27B | 11.08B | 9.44B | 8.95B | 8.86B |
| EBITDA | 6.11B | 5.29B | 5.58B | 3.79B | 3.66B | 3.90B |
| Net Income | 3.83B | 3.08B | 3.53B | 2.63B | 2.14B | 2.49B |
Balance Sheet | ||||||
| Total Assets | 44.93B | 42.66B | 41.15B | 40.08B | 35.63B | 35.77B |
| Cash, Cash Equivalents and Short-Term Investments | 6.54B | 13.34B | 10.50B | 11.65B | 10.37B | 9.78B |
| Total Debt | 6.18B | 2.42B | 2.26B | 2.29B | 2.43B | 2.95B |
| Total Liabilities | 15.83B | 12.74B | 13.25B | 15.44B | 13.65B | 14.97B |
| Stockholders Equity | 29.09B | 29.92B | 27.89B | 24.63B | 21.98B | 20.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.26B | -107.00M | 1.91B | 1.86B | 2.82B |
| Operating Cash Flow | 0.00 | 5.55B | 765.00M | 2.60B | 2.32B | 3.40B |
| Investing Cash Flow | 0.00 | -4.57B | -826.00M | -714.00M | -441.00M | -587.00M |
| Financing Cash Flow | 0.00 | -1.14B | -946.00M | -606.00M | -1.28B | -570.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €81.56B | 13.02 | 16.37% | 2.83% | 31.48% | 16.11% | |
76 Outperform | $121.17B | 14.74 | 12.54% | 1.65% | 13.86% | 51.05% | |
76 Outperform | ¥593.11B | 21.57 | ― | 1.40% | 7.87% | 38.32% | |
72 Outperform | ¥107.27B | 12.23 | ― | 3.64% | 2.46% | 533.70% | |
68 Neutral | ¥33.78B | 11.25 | ― | 2.76% | 0.18% | -18.93% | |
67 Neutral | ¥693.94B | 30.33 | 6.61% | 1.65% | 5.02% | -27.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |